JPWO2022230974A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022230974A5 JPWO2022230974A5 JP2023517621A JP2023517621A JPWO2022230974A5 JP WO2022230974 A5 JPWO2022230974 A5 JP WO2022230974A5 JP 2023517621 A JP2023517621 A JP 2023517621A JP 2023517621 A JP2023517621 A JP 2023517621A JP WO2022230974 A5 JPWO2022230974 A5 JP WO2022230974A5
- Authority
- JP
- Japan
- Prior art keywords
- nucleic acid
- region
- cov
- group
- pharma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021076521 | 2021-04-28 | ||
| PCT/JP2022/019273 WO2022230974A1 (ja) | 2021-04-28 | 2022-04-28 | 抗ウイルス核酸 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2022230974A1 JPWO2022230974A1 (https=) | 2022-11-03 |
| JPWO2022230974A5 true JPWO2022230974A5 (https=) | 2025-05-09 |
Family
ID=83848558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517621A Withdrawn JPWO2022230974A1 (https=) | 2021-04-28 | 2022-04-28 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20240229035A1 (https=) |
| EP (1) | EP4332223A4 (https=) |
| JP (1) | JPWO2022230974A1 (https=) |
| CN (1) | CN117203339A (https=) |
| TW (1) | TW202309282A (https=) |
| WO (1) | WO2022230974A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023171804A1 (ja) * | 2022-03-10 | 2023-09-14 | 日本新薬株式会社 | 抗ウイルスアンチセンスオリゴマー |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7339051B2 (en) * | 2003-04-28 | 2008-03-04 | Isis Pharmaceuticals, Inc. | Compositions and methods for the treatment of severe acute respiratory syndrome (SARS) |
| US20050171044A1 (en) * | 2003-12-24 | 2005-08-04 | Stein David A. | Oligonucleotide compound and method for treating nidovirus infections |
| PL2735568T3 (pl) * | 2006-05-10 | 2018-02-28 | Sarepta Therapeutics, Inc. | Analogi oligonukleotydowe mające kationowe połączenia pomiędzy podjednostkami |
| CN111321142A (zh) * | 2020-02-05 | 2020-06-23 | 翁炳焕 | 一种新型冠状病毒肺炎dsRNA疫苗的制备方法 |
| CN111330003A (zh) * | 2020-03-23 | 2020-06-26 | 翁炳焕 | 一种新冠肺炎反义rna多价疫苗的制备方法 |
| WO2021195025A1 (en) * | 2020-03-25 | 2021-09-30 | City Of Hope | Antisense rna for treatment of sars-associated coronavirus |
| CN111778253B (zh) | 2020-04-03 | 2022-02-18 | 苏州吉玛基因股份有限公司 | 一种小干扰核酸及组合物和应用 |
| CN111748557B (zh) | 2020-04-03 | 2022-03-11 | 苏州吉玛基因股份有限公司 | 抑制新型冠状病毒的小干扰核酸及组合物和应用 |
| WO2021224918A1 (en) * | 2020-05-07 | 2021-11-11 | Eleven Therapeutics Ltd. | Utilizing rna interference against sars-cov-2 |
| JPWO2021241040A1 (https=) * | 2020-05-27 | 2021-12-02 | ||
| CN112111489A (zh) * | 2020-06-23 | 2020-12-22 | 深圳罗兹曼国际转化医学研究院 | 抑制SARS-COV-2病毒复制的shRNA及其应用 |
| KR102272800B1 (ko) * | 2020-06-30 | 2021-07-05 | 국방과학연구소 | 코로나바이러스 특이적 이중가닥 올리고뉴클레오티드 및 이를 포함하는 코로나바이러스 감염증-19 예방 및 치료용 조성물 |
-
2022
- 2022-04-28 EP EP22795887.3A patent/EP4332223A4/en active Pending
- 2022-04-28 US US18/557,883 patent/US20240229035A1/en active Pending
- 2022-04-28 WO PCT/JP2022/019273 patent/WO2022230974A1/ja not_active Ceased
- 2022-04-28 TW TW111116238A patent/TW202309282A/zh unknown
- 2022-04-28 CN CN202280031074.4A patent/CN117203339A/zh not_active Withdrawn
- 2022-04-28 JP JP2023517621A patent/JPWO2022230974A1/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12252691B2 (en) | Compositions and methods for inhibiting LPA expression | |
| JP5875976B2 (ja) | 多価ｒｎａ干渉のためのポリヌクレオチド、組成物およびそれらの使用方法 | |
| DK1798285T3 (en) | Method and drug for inhibiting the expression of a given gene | |
| CN111819185A (zh) | 包含环状多核糖核苷酸的组合物及其用途 | |
| JP7432521B2 (ja) | 新規小分子活性化ｒｎａ | |
| RU2018144875A (ru) | Олигонуклеотиды, производящие переключение или модулирование сплайсинга пре-рнк и содержащие бициклические каркасные фрагменты, с улучшенными характеристиками для лечения генетических заболеваний | |
| CN111511914B (zh) | 减少PAPD5和PAPD7 mRNA的核酸分子用于治疗乙型肝炎感染 | |
| JP2008509670A5 (https=) | ||
| RS58982B1 (sr) | Lečenje hbv | |
| RU2014121304A (ru) | Ингибирование экспрессии вирусных генов | |
| CN121079412A (zh) | 经修饰的指导rna | |
| KR20170141257A (ko) | B형 간염 바이러스 (hbv) 감염의 치료를 위한 시약 및 이의 용도 | |
| JP2025166835A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｓｃａｍｐ３阻害剤の使用 | |
| CN114901821A (zh) | Sept9抑制剂用于治疗乙型肝炎病毒感染的用途 | |
| JPWO2022230974A5 (https=) | ||
| KR20180012255A (ko) | 이영양성 수포성 표피박리증 치료를 위한 안티센스 올리고뉴클레오타이드 | |
| CN112534055A (zh) | 用于调节rtel1表达的寡核苷酸 | |
| JP2025094072A (ja) | Ｂ型肝炎ウイルス感染を処置するためのｃｏｐｓ３阻害剤の使用 | |
| CN114867856A (zh) | Saraf抑制剂用于治疗乙型肝炎病毒感染的用途 | |
| CN118265787A (zh) | 抗病毒反义寡核苷酸 | |
| WO2022230974A1 (ja) | 抗ウイルス核酸 | |
| CN114829601A (zh) | Sbds抑制剂用于治疗乙型肝炎病毒感染的用途 | |
| JP7607884B2 (ja) | ＡＴＮ１ ｍＲＮＡ又はｐｒｅ－ｍＲＮＡを標的とするアンチセンスオリゴヌクレオチド | |
| EP1073731B1 (en) | Nucleic acid enzyme for rna cleavage | |
| JP2023161422A (ja) | 二本鎖領域を有する抗ウイルス核酸 |